The global Blood Filtration and Purification Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample preparation systems, Specialty assays and columns), By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others), By End-User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others).
The blood filtration and purification market is experiencing robust growth in 2025, driven by increasing applications in critical care, nephrology, oncology, and autoimmune disease management. Technologies such as plasma exchange (plasmapheresis), hemofiltration, leukocyte reduction, and immunoadsorption are expanding the therapeutic options for a wide range of conditions. Advanced membrane technologies and adsorption columns are improving the selectivity, efficiency, and biocompatibility of filtration systems. The rising demand for sepsis management, especially given its high mortality rate, underscores the importance of rapid blood purification devices in intensive care units (ICUs). Additionally, blood purification is playing an expanding role in novel treatments for cytokine storms (such as those seen in severe viral infections) and in enhancing recovery post-organ transplant. Emerging economies are focusing on setting up specialized apheresis centers, while developed countries are integrating these systems into multi-disciplinary critical care workflows, solidifying the market’s critical role in the modern medical landscape.
The market report analyses the leading companies in the industry including Avantor, Biotage, HiMedia, MilliporeSigma, MP Biomedicals., QIAGEN N.V, Roche lifescience, Sigma Aldrich, Takara Bio, Thermo Fischer Scientific, and others.
The blood filtration and purification market is witnessing a significant trend toward the development of next-generation membranes designed for highly selective filtration. Nanotechnology-enabled membranes, biomimetic surfaces, and adsorptive membranes capable of removing specific toxins, pathogens, or cytokines without compromising essential blood components are gaining traction. This trend is particularly important for critical care applications like sepsis management, organ support therapies, and immunotherapy-associated complications, where traditional hemodialysis systems are insufficiently precise.
The increasing use of extracorporeal blood purification therapies in intensive care units is a primary driver of market growth. Conditions such as sepsis, multi-organ failure, acute kidney injury, and autoimmune diseases often require immediate, life-saving blood filtration interventions. Furthermore, innovations like wearable or portable blood purification devices, combined with rising global awareness of the need for rapid toxin removal in critical cases, are fueling investments in advanced filtration technologies.
An exciting opportunity lies in creating customizable blood purification systems tailored to individual patient profiles. By leveraging real-time biomarker monitoring, AI-driven analysis, and adjustable filtration parameters, companies could develop systems that adapt dynamically to a patient’s evolving physiological state during therapy. Such personalized solutions could dramatically improve treatment efficacy, reduce side effects, and enable broader adoption in not just critical care but also chronic disease management, such as autoimmune disorders or cancer-related complications.
The Filters and Consumables segment is expected to dominate the blood filtration and purification market revenue in 2025, driven by the recurring demand for disposable components in a wide range of therapeutic and diagnostic applications. Filters and consumables are critical to maintaining the sterility, efficacy, and safety of blood processing systems, particularly in procedures like hemodialysis, leukoreduction, plasma separation, and therapeutic apheresis. The rising incidence of chronic kidney diseases, autoimmune disorders, and blood-borne infections globally has led to a steady uptick in demand for blood purification therapies, directly boosting the consumption of filtration consumables. Moreover, healthcare providers prioritize single-use consumables to minimize the risk of cross-contamination and meet stringent infection control protocols, further reinforcing the need for these products. With growing investments in biopharmaceutical manufacturing and advanced blood therapies, the filters and consumables segment is set to be the most significant revenue contributor by 2025.
The cancer diagnostics segment is anticipated to register the fastest growth in the blood filtration and purification market through 2034, propelled by the rising global cancer burden and growing demand for liquid biopsy techniques. As oncology increasingly moves toward precision medicine, blood-based diagnostics are becoming central to non-invasive cancer detection, monitoring, and treatment planning. Blood filtration systems that isolate circulating tumor cells (CTCs), cell-free DNA (cfDNA), and exosomes are witnessing accelerated adoption across clinical and research settings due to their ability to provide real-time, dynamic insights into tumor progression. The continued expansion of immunotherapies and targeted biologics further increases the demand for purified, analyzable blood samples that support biomarker-driven decisions. Additionally, regulatory approvals of novel blood-based diagnostic platforms and increasing integration of AI in cancer screening protocols are contributing to this segment's rapid growth, particularly as healthcare systems seek cost-effective, scalable alternatives to tissue biopsies.
China's blood filtration and purification market is experiencing rapid growth, driven by the increasing prevalence of kidney diseases, cardiovascular diseases, and infections that require effective blood filtration. As one of the largest healthcare markets globally, China has made significant advancements in medical technology, improving access to life-saving treatments such as dialysis. The rising incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a major factor boosting the demand for blood purification systems, such as hemodialysis machines and blood filtration devices. In addition to the aging population, environmental factors and dietary changes are contributing to an uptick in the incidence of blood-borne diseases. The government’s support for healthcare innovation, along with increased spending on medical infrastructure, is enhancing the adoption of advanced blood filtration technologies. Furthermore, with an increasing focus on precision medicine, the demand for personalized blood purification treatments tailored to the patient's specific needs is also growing. Innovations such as high-efficiency filters, combined with improved renal replacement therapy (RRT), are gaining traction in China’s healthcare market, driving the expansion of the blood filtration and purification sector.
In India, the blood filtration and purification market is gaining momentum due to a high burden of chronic diseases, particularly kidney-related ailments, diabetes, and hypertension, which are primary contributors to the need for blood purification treatments. The market is fueled by the increasing demand for hemodialysis and peritoneal dialysis, which are essential for patients with kidney failure. India’s healthcare infrastructure, especially in urban areas, is expanding rapidly, with private healthcare providers and hospitals adopting cutting-edge blood filtration technologies to meet growing demand. The rising middle class and increasing awareness about the importance of early diagnosis and treatment of chronic diseases are further driving the market. While healthcare facilities in metropolitan cities like Mumbai and Delhi are witnessing high demand for advanced filtration systems, rural areas continue to face challenges in accessing specialized treatments. However, the government's healthcare initiatives, including the National Dialysis Program, are improving access to affordable blood filtration and purification treatments across the country. Innovations in low-cost dialysis machines and mobile dialysis units are helping to address the demand for these devices in underserved areas.
The United States remains a global leader in the blood filtration and purification market, largely due to its advanced healthcare infrastructure and high incidence of chronic diseases such as kidney disease, diabetes, and hypertension. The demand for dialysis services continues to rise, driven by an aging population and the growing prevalence of kidney disorders. With the increasing burden of end-stage renal disease (ESRD) in the country, there is a rising need for blood filtration systems such as hemodialysis machines, continuous renal replacement therapy (CRRT), and blood purification filters. The U.S. is also witnessing a shift toward home-based dialysis, which is driving the development of portable blood purification devices. Innovations such as artificial kidneys, bio-compatible filters, and automated blood purification systems are further enhancing the market. The strong regulatory framework provided by the FDA ensures that only the most effective and safe blood purification devices are available in the market, bolstering the confidence of both healthcare providers and patients. Additionally, the growing focus on chronic disease management and personalized treatment plans is accelerating the demand for blood filtration and purification technologies in the U.S.
Germany is one of the key markets for blood filtration and purification in Europe, supported by its robust healthcare infrastructure, a high standard of medical care, and strong emphasis on preventative healthcare. The country has witnessed an increase in demand for hemodialysis treatments due to an aging population and a rising incidence of chronic diseases, such as hypertension and diabetes, which are significant contributors to kidney diseases. As part of the broader European Union healthcare initiatives, Germany is also focused on enhancing access to dialysis treatments, which in turn stimulates the demand for blood filtration systems. In addition to standard blood purification methods, there is a growing trend towards advanced dialysis technologies such as high-flux dialysis, which improves patient outcomes and enhances quality of life. Germany is also home to several leading medical device manufacturers, contributing to continuous innovation in the blood filtration and purification market. The growing preference for minimally invasive procedures and home dialysis solutions is also shaping the market landscape, with companies investing in portable and user-friendly blood purification devices that can be used outside of traditional healthcare settings.
The blood filtration and purification market in France is expanding due to the rising incidence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD). The demand for hemodialysis and peritoneal dialysis is growing, supported by an aging population and increased life expectancy. French healthcare providers are increasingly adopting advanced blood purification technologies, such as hemodialysis machines, blood filtration devices, and CRRT systems, to improve patient outcomes. The government’s strong focus on healthcare accessibility, combined with an increase in private sector investment, has made blood filtration technologies more widely available across the country. Additionally, France is witnessing a rise in the number of patients opting for home dialysis solutions, creating a demand for portable blood purification devices. Innovations in personalized medicine, such as genetic-based treatments for kidney diseases, are also driving market growth, as French medical researchers and institutions continue to explore new ways to enhance dialysis therapy and improve the quality of life for patients. The adoption of new filtration technologies and a growing emphasis on early detection and treatment of kidney disease are contributing to the expansion of the market in France.
The Middle East’s blood filtration and purification market is experiencing rapid growth, particularly in countries like the UAE, Saudi Arabia, and Qatar, which are investing heavily in healthcare infrastructure to cater to their growing populations and increasing demand for healthcare services. The rising prevalence of kidney diseases, diabetes, and hypertension, compounded by an aging population, is significantly driving the need for blood filtration and purification systems in the region. The adoption of advanced hemodialysis machines and continuous renal replacement therapy (CRRT) is on the rise, supported by both public and private healthcare initiatives. Additionally, the Middle East is witnessing a surge in medical tourism, particularly for renal treatments, which is contributing to the demand for advanced blood purification technologies. The government’s investment in healthcare technology, along with the growing preference for minimally invasive and efficient medical treatments, is driving the market. The increasing awareness about kidney disease management and early detection, along with the adoption of home dialysis solutions, is further influencing the demand for blood filtration devices in the Middle East.
Parameter |
Details |
Market Size (2025) |
$4.1 Billion |
Market Size (2034) |
$8 Billion |
Market Growth Rate |
7.7% |
Segments |
By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample preparation systems, Specialty assays and columns), By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others), By End-User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others) |
Study Period |
2019- 2024 and 2025-2034 |
Units |
Revenue (USD) |
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
Companies |
Avantor, Biotage, HiMedia, MilliporeSigma, MP Biomedicals., QIAGEN N.V, Roche lifescience, Sigma Aldrich, Takara Bio, Thermo Fischer Scientific |
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Product
Filtration Kits and Reagents
Membranes, Filters and Consumables
Sample preparation systems
Specialty assays and columns
By Application
Infectious Disease Diagnostics
Toxicology and Immunodiagnostics
Cancer Diagnostics
Genetic/Molecular Diagnostics
Others
By End-User
Clinical Diagnostic Labs
Hospitals
Research and Academic Institutes
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Avantor
Biotage
HiMedia
MilliporeSigma
MP Biomedicals.
QIAGEN N.V
Roche lifescience
Sigma Aldrich
Takara Bio
Thermo Fischer Scientific
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Blood Filtration and Purification Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Blood Filtration and Purification Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Blood Filtration and Purification Market Size by Segments, 2018- 2024
Key Statistics, 2024
Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Blood Filtration and Purification Types, 2018- 2024
Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Blood Filtration and Purification Applications, 2018- 2024
8. Blood Filtration and Purification Market Size Outlook by Segments, 2024- 2034
By Product
Filtration Kits and Reagents
Membranes, Filters and Consumables
Sample preparation systems
Specialty assays and columns
By Application
Infectious Disease Diagnostics
Toxicology and Immunodiagnostics
Cancer Diagnostics
Genetic/Molecular Diagnostics
Others
By End-User
Clinical Diagnostic Labs
Hospitals
Research and Academic Institutes
Others
9. Blood Filtration and Purification Market Size Outlook by Region
North America
Key Market Dynamics
North America Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2021-2034
North America Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2021-2034
North America Blood Filtration and Purification Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Blood Filtration and Purification Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2021-2034
Europe Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2021-2034
Europe Blood Filtration and Purification Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Blood Filtration and Purification Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Blood Filtration and Purification Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Blood Filtration and Purification Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2021-2034
South America Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2021-2034
South America Blood Filtration and Purification Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Blood Filtration and Purification Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Blood Filtration and Purification Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Blood Filtration and Purification Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Blood Filtration and Purification Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Blood Filtration and Purification Market Size Outlook by Country, USD Million, 2021-2034
10. United States Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
United States Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
United States Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
11. Canada Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Canada Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Canada Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
12. Mexico Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Mexico Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Mexico Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
13. Germany Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Germany Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Germany Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
14. France Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
France Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
France Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
France Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
United Kingdom Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
United Kingdom Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
16. Spain Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Spain Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Spain Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
17. Italy Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Italy Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Italy Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
18. Benelux Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Benelux Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Benelux Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
19. Nordic Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Nordic Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Nordic Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Rest of Europe Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Rest of Europe Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
21. China Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
China Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
China Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
China Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
22. India Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
India Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
India Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
India Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
23. Japan Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Japan Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Japan Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
24. South Korea Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
South Korea Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
South Korea Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
25. Australia Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Australia Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Australia Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
26. South East Asia Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
South East Asia Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
South East Asia Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
28. Brazil Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Brazil Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Brazil Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
29. Argentina Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Argentina Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Argentina Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Rest of South America Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Rest of South America Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
United Arab Emirates Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
United Arab Emirates Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Saudi Arabia Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Saudi Arabia Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Rest of Middle East Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Rest of Middle East Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
34. South Africa Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
South Africa Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
South Africa Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Blood Filtration and Purification Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Blood Filtration and Purification Market Size Outlook by Type, 2021- 2034
Rest of Africa Blood Filtration and Purification Market Size Outlook by Application, 2021- 2034
Rest of Africa Blood Filtration and Purification Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Avantor
Biotage
HiMedia
MilliporeSigma
MP Biomedicals.
QIAGEN N.V
Roche lifescience
Sigma Aldrich
Takara Bio
Thermo Fischer Scientific
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Product
Filtration Kits and Reagents
Membranes, Filters and Consumables
Sample preparation systems
Specialty assays and columns
By Application
Infectious Disease Diagnostics
Toxicology and Immunodiagnostics
Cancer Diagnostics
Genetic/Molecular Diagnostics
Others
By End-User
Clinical Diagnostic Labs
Hospitals
Research and Academic Institutes
Others
The Global Blood Filtration and Purification Market Size is estimated at $4.1 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 7.7% to reach $8 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Avantor, Biotage, HiMedia, MilliporeSigma, MP Biomedicals., QIAGEN N.V, Roche lifescience, Sigma Aldrich, Takara Bio, Thermo Fischer Scientific
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume